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The kinetoplastidae are flagellated protozoans that are widely distributed in nature and 
cause diseases in both plants and vertebrates.   They are distinguished by presence of 
kinetoplast, that is, the DNA-containing region in their single large mitochondrion.   The 
diseases in crops and lifestocks cause considerable economic loss while serious human 
suffering and death occur in infections in man.   In humans, the diseases include 
trypanosomiasis, leishmaniasis and chagasis.   Trypanosomiasis is caused by infection with 
two of the three subspecies of Trypanosoma brucei; Chagas disease is caused by infection with 
Trypanosoma cruzi and various forms of leishmaniasis are caused by different species of 
Leishmania.  These forms of diseases have been classified by the World Health Organization 
(WHO) as major tropical diseases. According to WHO estimates, about 12 million people 
suffer from the disease but close to 350 million people in 80 countries world-wide are at risk 
(Anon, 1990).   They are endemic in tropics, subtropics and southern Europe in settings 
ranging from rain forests in the Americas to deserts in Asia and Middle East.  The cellular 
biology of these kinetoplastids is essentially similar, for example, they are all motile 
protozoans with a single flagellum that originates close to their large single mitochondrion.  
They all have glycosomes, that is, micro-bodies that perform glycolysis.   All typically grow 
asexually although sexual recombination has been shown or inferred but is not obligate in 
any one of them.  They divide by binary fission during which their nucleus does not 
undergo membrane dissolution or chromosome condensation.  They are well adapted to 
their hosts and evade immune elimination by antigenic variation, and alteration of immune 
responsiveness.   There is no effective immune response against human trypanosomiasis 
which invariably results in fatality. In the case of T. cruzi and Leishmania spp., the immune 
response tends to control rather than eliminate them.    
Leishmaniases constitute a broad spectrum of diseases, including the localized cutaneous 
and the disseminated visceral and mucocutaneous forms. Cutaneous and mucosal 
leishmaniases cause chronic skin sores and facial disfigurement respectively while untreated 
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visceral leishmaniasis, otherwise known as kala-azar, causes life-threatening systemic 
infection.   There are a total of about 21 leishmanial species that cause leishmaniases and 
these are transmitted by about 30 species of phlebotomine sandflies (Desjeux 1996, Ashford 
1997).   Globally, leishmaniasis caused approximately 59000 deaths and 2.4 million disability 
adjusted life years in 2001 (World Health Organization Report, 2001).   The life cycle of 
Leishmania involves two stages, a stage in the sand fly vectors where they exist mostly as 
promastigotes and another stage in the mammalian host.    The promastigotes are injected 
into human host where they invade the macrophages by receptor-mediated endocytosis, 
transforming into amastigotes that multiply by binary fission. 
Leishmaniasis is a treatable disease, however, the antileishmanial therapy is bewildering 
largely because of the complexities of the disease.   The few effective agents available 
generally are potentially  toxic and mostly are difficult to administer.   Furthermore the 
treatment  of cutaneous leishmaniasis, for example, is often complicated by rapid self 
healing making it difficult to assess efficacy of trials.   The pentavalent antimony 
compounds, sodium stibogluconate (Pentostam, Glaxo Wellcome, UK) and meglumine 
antimonite (Glucantime, Rhône-Poulenc Rorer, France) have been the mainstays of 
antileishmanial therapy since 1940s (Berman,  1997, Herwaldt & Berman 1999).    These 
drugs, although, effective suffer from disadvantages of long duration of therapy, parenteral 
mode of administration, almost always reversible toxic effects among other disadvantages.   
Other new approaches to management of leishmaniasis have some merits but unfortunately 
most of the non-parenteral agents that have been assessed at best have modest activity 
against a limited range of species and strains (Herwaldt & Berman, 1992). New effective, 
safe and affordable drugs are needed for all kinetoplastids.  It will be better to have more 
than one new drug so that combination therapy can be employed whenever drug resistance 
arises and also provide back-up when resistance emerges. 
Kinetoplastids have been useful for study of fundamental molecular and cellular 
phenomena like antigenic variation, RNA editing and mRNA trans-splicing (Borst & 
Rudenko, 1994, Stuart, 1991, Perry & Agabian, 1991).   The comparison of their sequences 
with other eukaryotes may be useful in identification of ancient conserved motifs 
considering their early evolutionary divergence.  Also their protein sequence may be a 
useful source of diversity for protein engineering. 
Rational development of anti-leishmanial drugs that will exploit biochemical differences 
between host and parasite is most desirable.     
There are challenges to achieving this goal but with current available technologies, it is 
possible.  With post-genomic bioinformatics and experimental research, it is possible to 
identify drug targets, vaccine candidates and pathogenic processes.  It is also possible to 
identify candidate diagnostics which realistically should be non-invasive, inexpensive and 
deployable at the poor resource sites. The new diagnostics in addition should discriminate 
between types of diseases. 
Ribose metabolism in Leishmania is of interest because like in other protozoa parasites, it is 
auxotrophic for purines and expresses multiple pathways for purine uptake (Landfear et al., 
2004) and salvage (Hwang & Ulman, 1997) that enable it to acquire and use these vital 
metabolites from the hosts.   A metabolic pathway of interest is that involved in production 
of ribose 5-phosphate (R5P) required for the synthesis of 5-phosphoribosyl-1-pyrophosphate 
used with nucleobases for the synthesis of nucleic acids.   Classically ribose 5-phosphate is 
generated in cells by one or combination of the following pathways:   
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• Ribokinase conversion of ribose (reaction 1) 
• Condensation of fructose 6-phosphate and glyceraldehyde 3-phosphate mediated by 
transaldolase and transketolase (reaction 2). 
• Conversion of glucose via oxidative pathway of pentose phosphate pathway 
(reaction 3). 
• Hydrolysis of nucleoside to nucleobase and ribose followed by reaction 1 
The stoichiometric expressions of these reactions are: 
1. Ribose + ATP                       R5P + ADP 
2. 2F6P + G3P        3R5P 
3. G6P + 2NADP+ + H2O R5P + 2NADPH 2H+ + H2O 
4. Nucleoside  Base + Ribose  R5P 
Reaction 4 is unique to trypanosomatids including Leishmania .   
The consequence of reaction 4, that is the nucleoside hydrolase activity, is the abundance of 
intracellular ribose available to Leishmania parasites.   The extracellular ribose has been 
shown previously to be efficiently incorporated into the nucleic acids of leishmania 
(Maugeri et al., 2003).   Ribose may also serve as a source of energy for organisms (Berens et 
al., 1980) hence there is every need to study the enzyme (ribokinase) that is involved in the 
mobilization of ribose.      Ribokinase is an ATP-dependent phosphoribosyl kinase (EC 
2.1.7.15), which catalyses the conversion of ribose to ribose 5-phosphate, a substrate of 5-
phosphoribosyl 1-pyrophosphate synthatase, that uses nucleobases and ribose 5-phosphate 
to synthesize nucleic acids.    X-ray crystallography of Escherichia coli ribokinase shows the 
protein to be a homodimer in solution with each subunit having two domains.   Each 
subunit has a molecular weight of about 33 KDalton (Sigrell et al., 1997, Sigrell et al., 1998, 
Sigrell et al., 1999).    The turnover numbers for Leishmania ribokinase for the substrates D-
ribose and ATP are respectively10.8 s-1 and 10.2 s-1 and the catalytic activity is strongly 
dependent on the presence of monovalent cations(Ogbunude et al., 2003, Chuvikovsky et al., 
2006). 
Because of these important roles played by ribokinase in Leishmania metabolism, we cloned 
the genes for the enzyme and expressed it in E coli as previously published (Ogbunude et al., 
2007).  Here we summarize the method used in cloning and expression of the enzyme. 
2. Materials and methods 
2.1 Chemicals 
Synthetic oligonucleotides were obtained from MWG-Biotech AG, UK.   All restriction and 
DNA modifying enzymes were obtained from Promega (UK) or Roche, Roche Diagnostics 
GmbH, Germany. All other chemicals and reagents were of the highest quality 
commercially available. 
2.2 Methods 
2.2.1 Culture of L.major promastigotes 
The L. major promastigotes (MHOM/JL/80/Friedlin) were grown in tissue culture flasks in 
HOMEM medium supplemented with heat-inactivated 10% fetal bovine serum at 27oC.   
Promastigotes were harvested at approximately 107 cells/ml at the end of logarithmic growth 
phase.   Following isolation and washing in wash buffer (50 mM Tris-HCl, pH 8.0), the 
genomic DNA of the promastigotes was isolated by published procedures with some 
www.intechopen.com
  
Molecular Cloning – Selected Applications in Medicine and Biology 
 
224 
modifications (Wilson et al., 1991).    Briefly, promastigotes were resuspended to a density of 5 
x 109 per 450 µl in 50 mM Tris-HCl, pH8, 50 mM EDTA, 100 mM NaCl.  50 µl of 10% SDS was 
added to this mixture with 50 µl of proteinase type IV (40 mg ml-1 stock) and 2000 U ml-1 
RNAse inhibitor.  The mixture was incubated at 37oC for 2 hours with intermittent shaking.   
To the mixture an equal quantity of phenol was added and then the supernatant collected and 
an equal volume of 3:1 v/v phenol/chloroform added to this supernatant.  After mixing and 
separation of the phases by centrifugation the aqueous phase was again taken and this time 
mixed with 4 volumes of chloroform.  The supernatant was collected, and 0.1 volumes of 3 M 
sodium acetate (pH 7.0) added followed by 2.5 volumes of ethanol.  Nucleic acid was left to 
precipitate at –20oC overnight and then collected by centrifugation.  The precipitate was 
washed once in 70% ethanol, air-dried and then dissolved in 50 µl of double distilled H2O. 
2.2.2 Design of oligonucleotide primers 
The gene coding a putative ribokinase was identified in the L. major genome using BLAST 
searches with ribokinase of diverse organisms (Fig 1).   Oligonucleotide primers were 
designed against conserved regions of proteins, which represented an open reading frame.   
The forward primer (5′-AAACATATGCACCGTGTGCAGAACGTT-3′) was designed from 
the first peptide of the protein while the reverse (5′-
AAACTCGAGCTACGTGACACCAGCC-3′) was designed from the second peptide.   The 
underlined bases represent restriction sites (Nde1 and xho1) that were inserted to facilitate 
cloning of the PCR amplified products.   The oligonucleotides were synthesized by MWG-
Biotech AG, UK. 
2.2.3 PCR amplification 
Amplification was carried out in a DNA thermal cycler (MJ Research Inc., Western Town, 
MA, USA).   PCR was routinely performed in 100 µl reaction containing 10 mM Tris-HCl, 
pH 8.3, 1.5 mM MgCl2, 50 µM KCl, 200 µM each of dNTPs, 40 ng of each of the primer and 1 
unit of Pfu DNA polymerase.   The tube containing the reactants were placed in the thermo 
cycler programmed for 30 cycles, a single cycle at 94oC for 120 s; was followed by 30 cycles 
at 63oC for 15 s and 72oC for 120 s; with a final cycle at 72oC for 600 s. 
2.2.4 Detection of PCR products 
Five micro liters of the PCR product was electrophoresed in a 1% agarose gel containing 0.1 
µg of ethidium bromide per ml, and bands were visualized by UV transillumination. 
2.2.5 Preparation of cloning vector and insertion 
The amplified DNA, after gel electrophoresis was isolated using the commercially available 
QIAquick Gel Extraction Kit (Qiagen, West Sussex).   The gel-purified PCR product (1.2-kb 
amplicon) was cut with Nde1 and xho1 at the primer sequence sites underlined.    This was 
ligated with the pGEM-T Easy plasmid (Novagen) cut with the same enzymes.   The 
recombinant plasmid was introduced into E. coli strain DH5α (Invitrogen) by heat 
transformation in Luria broth (LB) medium at 42oC for 50 sec.  Agar plates with LB medium 
supplemented with ampicillin, isopropyl-1-thio-β-D-galactopyranoside (IPTG) and 5-
bromo-4-chloro-3-indolyl-β-galactoside (X-gal) were used to test the recombinant strain. 
Positive strain was used for recombinant protein over-expression experiments. 
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2.2.6 Protein overproduction 
For recombinant protein over expression, the Nde 1 and xho 1 digest of pGEM-T was 
inserted between the same sites of plasmid pET28a+ (Novagen).   The resulting plasmid 
pET28a+ribo construct harbors the rbk gene under the control of a hybrid promoter-
operator region, consisting of sequence of T7 promoter and a lac operator. The 
pET28a+ribo was introduced into the BL21 (strain DE3)(Statagene) for protein over 
expression.   Expression of the His-tagged ribokinase was induced by 0.5 mM IPTG 
overnight at room temperature. Cells were harvested by centrifugation, washed once and 
stored at –20oC in 5 ml of 50 mM Hepes buffer, pH 7.0 containing 300 mM NaCl and 10 
mM EDTA. The cells were lysed by sonication in buffer A (50 mM NaH2PO4 containing 
300 mM NaCl, pH 8.0) and the soluble fraction recovered by centrifugation at 10,000 g for 
30 min at 4oC. This was applied to nickel-nitrilotriacetic acid column (bioCAD) pre-
equilibrated with the buffer A.   The column was washed with 100 ml of the buffer A 
containing 0.5 mM imidazole and then with the same buffer containing 50 mM imidazole 
and finally the his-tagged recombinant protein was eluted with 500 mM imidazole in the 
buffer A.   The eluant was dialysed overnight in 50 mM Tris-HCl, pH 7.0 at 4oC and stored 
at –70oC in buffer/glycerol (1:1). 
3. Results 
Data base searches of L. major ribokinase sequence revealed a gene in chromosome 27 
(LmjF27.0420 )  with an open reading frame of 990 base pairs encoding a 329 amino acid 
protein orthologous with ribokinase from other organisms .  Figure 1 shows the alignment 
of this protein with ribokinase from phylogenetically diverse organisms.  The alignment 
revealed a high degree of conservation of primary structure among the four aligned 
proteins. 
The SDS-Page analysis of the bacterial extract shown in figure 2 demonstrated protein 
overproduction at the expected molecular weight of 34 Kdalton.  The Coomassie staining 
indicated that the recombinant protein represented more than 90% of the total protein.  
After purification, the enzyme was judged to be over 95%homogenous. 
The figure 3 graph shows time dependence of conversion of ribose to R5P.   In this coupled 
assay system, ADP is utilized by phosphoenolpyruvate in reaction catalyzed by pyruvate 
kinase to regenerate ATP and the resulting pyruvate is converted by lactate dehydrogenase 
to lactate and in the process NADH is oxidized to NAD+.   The reaction was followed at 340 
nm as a decrease in NADH absorbance when converted to NAD+. The reaction 
demonstrates that the recombinant protein is indeed a functional enzyme.  The enzyme 
when stored at -70oC in buffer/glycerol (1:1) retained more than 50% of  activity after a year. 
It retained full activity for two months when stored at -70oC with or without glycerol.  The 
enzyme is highly specific for D-ribose in species so far studied although it insignificantly 
phosphorylates other five and six carbon sugars like D-arabinose, D-xylose, D-galactose and 
D-fructose.  The catalytic efficiency for catalysis of D-ribose ranges from 10.8 s-1 mM-1 to 40.6 
s-1 mM-1 while it is in the order of 0.05 s-1 mM-1 to 1.8 s-1 mM-1 for other D-sugars.    The 
ribokinae activity depends absolutely on the presence of inorganic phosphate.  Omission of 
inorganic phosphate from reaction mixture reduced the enzyme activity to insignificant 
level.   
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Fig. 1. Alignment of a putative ribokinase gene product from L. major with ribokinase     
sequences  from S. cerevisiae  E. coli and H. sapiens. 
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Fig. 2. SDS-Page analysis of bacterial extract 
The SDS-Page (12.5% polyacrylamide) analysis of the bacterial extract shows protein 
overproduction at the expected molecular weight of 34,000 daltons.   The 1kb molecular 
weight marker which served as a control is in Lane 1. Lanes 2, 3 and 4 are fractions collected 
at intervals from the nickel-nitrilotriacetic acid column. 
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Fig. 3. Time dependence of conversion of ribose to ribose 5-phosphate by ribokinase  
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The interest in the uptake and metabolism of ribose as a potential metabolic supplement has 
justified the cloning and characterization of the enzyme.  Administration of exogenous ribose 
for instance have been shown to increase both the repletion and maintenance of high level of 
ATP in various types of cells (Smolenski et al., 1998, St Cyr et al., 1989) and maintenance of 
higher levels of ATP in rat heart and dog kidney during transplantation experiments (Muller et 
al, 1998).   Thus ribose has potential therapeutic applications involving cardiovascular cells.   
Studies into the major carbon sources used by intracellular Leishmania amastigotes show that L. 
mexicana mutant lacking the three high affinity hexose transporters was unable to establish 
infection in macrophages or susceptible mice (Burchmore et al., 2003), indicating that hexose 
uptake is essential for intracellular growth.  The levels of hexose in the phagolysosome may, 
however, be limiting as  mutant L. major amastigotes that have defect in gluconeogenesis was 
also found to be poorly virulent in macrophages and susceptible mice (Nadereer et al., 2006).  
These studies indicate that intracellular amastigotes depend on both salvage and de novo 
synthesis of hexoses.   The phagolysosome of macrophages could however contain a range of 
other sugars including ribose which could be used directly as an energy source with the 
pentose phosphate pathway ( Barrett 1997, Maugeri et al., 2003) shunting intermediates into 
the glycolytic pathway. 
In parasitic organism such as Leishmania which, lacks purine nucleoside phosphorylase 
enzyme and instead has high activity of purine nucleoside hydrolase, the organism will 
generate high concentration of intracellular ribose.   As well, it accumulates ribose from the 
host via a specific carrier-mediated protein (Pastakia & Dwyer, 1987).   That ribose is 
encountered throughout the life cycle of the parasite is well known (Burchmore & Barrett, 
2001).  In absence of glucose in culture medium, ribose served as a substitute and became 
essential for the growth of the Leishmania promastigotes (Steiger & Black, 1980).  Thus ribose 
plays an important role in the metabolism of Leishmania.  For ribose to be utilized, it must be 
converted to ribose 5-phosphate by ribokinase, hence the interest in identifying and cloning 
of this enzyme responsible for this critical first step in ribose metabolism. 
The ribokinase gene has been identified from variety of sources including human, E. Coli 
and Leishmania.  There is a high degree of similarity between the ribokinase gene from 
animal (human) and that from E. Coli (Park et al., 2007). The structure of ribokinase as 
revealed by X-ray crystal structure of E.coli shows that it is a homodimer in solution with 
each subunit composed of two domains (Sigrell et al., 1997, Sigrell et al., 1998, Bork et al., 
1993).  Also the crystallographic studies show that oxygen atoms of the α-D-pentofuranose 
ring are involved in hydrogen bonding interactions between the enzyme and the substrates, 
ribose and ADP (Andersson & Mowbray 2002, Maj & Gupta 2001).  The amino acids 
residues, asparagines and glutamic acid, at sequence positions 187 and 190, appear to be 
conserved in all the species studied and have been shown to be the site for phosphate 
binding (Park et al. 2007). Site directed mutation of these amino acid residues have led to 
formation of mutant enzymes with altered MgATP2+ and phosphate requirements (Parducci 
et al., 2006). 
In summary, L. major has a gene that expressed functional ribokinase.  The enzyme was 
specific for D-ribose and did not phosphorylate related sugars unlike what was seen with 
E.coli ribokinase that phosphorylated related sugars to a minor degree. Presently, it is not 
known whether the enzyme is essential.  A lot more information is still required before 
specific compounds are designed to target the enzyme for chemotherapy. 
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